Jeannette Bankes - May 15, 2025 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Stock symbol
GEHC
Transactions as of
May 15, 2025
Transactions value $
$0
Form type
4
Date filed
5/19/2025, 04:27 PM
Previous filing
May 1, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bankes Jeannette CEO, Patient Care Solutions 500 WEST MONROE STREET, CHICAGO /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 2025-05-19 0001920839

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +30.2K $0.00 30.2K May 15, 2025 Direct F1, F2
transaction GEHC Common Stock, par value $0.01 per share Award $0 +6.86K +22.72% $0.00 37K May 15, 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +18.8K $0.00 18.8K May 15, 2025 Common Stock, par value $0.01 per share 18.8K $72.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
F2 Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on May 15, 2026, and 50% will vest on May 15, 2027.
F3 Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2026, 33% will vest on September 1, 2027, and 34% will vest on September 1, 2028.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2026, 33% will become exercisable on September 1, 2027, and 34% will become exercisable on September 1, 2028.